SCHEMBL28588636

SCHEMBL28588636

CC(C)(C)OC(=O)NC(=N)c1ccc2cc(C(=O)O)n(-c3ccc4ccccc4c3)c2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ GABRB1 P18505 1/20 0.42
▸ GABRB2 P47870 1/20 0.42
▸ PLA2G10 O15496 5/20 0.36
▸ PTGES O14684 2/20 0.36
▸ CTSB P07858 1/20 0.36
▸ CTSS P25774 1/20 0.36
▸ CTSK P43235 1/20 0.36
▸ MCL1 Q07820 1/20 0.35
▸ NR1H2 P55055 2/20 0.33
▸ KAT6A Q92794 1/20 0.33
▸ PHGDH O43175 1/20 0.33
▸ DAO P14920 1/20 0.33
▸ PLA2G2A P14555 3/20 0.33
▸ PLA2G5 P39877 3/20 0.33
▸ ACACB O00763 1/20 0.32
▸ PPARG P37231 1/20 0.32
▸ PPARD Q03181 1/20 0.32
▸ PPARA Q07869 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28573693 0.80 KDM4E (0.51) ACACB
SCHEMBL21822442 0.78 ALDH1A1 (0.52) ALDH1A1TSHRPLA2G10MCL1DAO
SCHEMBL31689665 0.78 ALDH1A1 (0.52) ALDH1A1TSHRPLA2G10MCL1DAO
SCHEMBL21822737 0.77 CTSS (0.42) CTSSCTSKMCL1
SCHEMBL31689662 0.77 CTSS (0.42) CTSSCTSKMCL1
SCHEMBL25016769 0.75 F10 (0.44) —
SCHEMBL21822112 0.75 NQO2 (0.37) GABRB1GABRB2CTSSCTSKMCL1
SCHEMBL31689687 0.75 NQO2 (0.37) GABRB1GABRB2CTSSCTSKMCL1
SCHEMBL5247396 0.73 ALDH1A1 (0.76) ALDH1A1TSHRPLA2G10MCL1DAO
SCHEMBL7158402 0.70 PPARG (0.47) ALDH1A1TSHRCTSBCTSSCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3860636-B1 MATRIPTASE 2 INHIBITORS AND USES THEREOF DISC MEDICINE INC (US) 2026-01-28 — — EP disclosed
US-12428415-B2 Matriptase 2 inhibitors and uses thereof DISC MEDICINE, INC. (US) 2025-09-30 — — US disclosed
US-20230043159-A1 MATRIPTASE 2 INHIBITORS AND USES THEREOF DISC MEDICINE, INC. 2023-02-09 — — US disclosed
CN-112996529-A Matriptase 2 inhibitor and application thereof 迪斯克医药公司 2021-06-18 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12428415-B2 Matriptase 2 inhibitors and uses thereof MMP7, MATR3, SPINT2 ALDH1A1 3877/4885TSHR 4421/4885GABRB1 4662/4885
US-20230043159-A1 MATRIPTASE 2 INHIBITORS AND USES THEREOF MMP7, MATR3, SPINT2 ALDH1A1 3877/4885TSHR 4421/4885GABRB1 4662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback